Author:
Li Zhong-hao,Pu Xiao-qi,Li Sha-sha,Dong Xiao-ke,Zhang Guo-qiang,Wang Yu,Liu Jin-min
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021;20:795–820.
2. Wang YJ, Li ZX, Gu HQ, Zhai Y, Zhou Q, Jiang Y, et al. China stroke statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. Stroke Vasc Neurol 2022;7:415–450.
3. Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019;18:394–405.
4. Wang XF, Yuan RR, Zhao JY, Qian RY. Meta-analysis of Tanreqing Injection in adjuvant treatment of stroke-associated pneumonia. China J Chin Mater Med (Chin) 2021;46:4265–4273.
5. Zheng X, Lin H, Zhou Q, Wang X, Sun H. Clinical efficacy and safety evaluation of the combination of Tanreqing and thymosin in stroke patients with pulmonary infection. Anti Infect Pharm 2016;13:478–480.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献